Previous close | 27.70 |
Open | 27.86 |
Bid | 27.83 x 2900 |
Ask | 27.77 x 2200 |
Day's range | 27.52 - 27.91 |
52-week range | 25.20 - 40.37 |
Volume | |
Avg. volume | 41,442,888 |
Market cap | 157.475B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.05 |
Earnings date | 30 July 2024 - 05 Aug 2024 |
Forward dividend & yield | 1.68 (6.04%) |
Ex-dividend date | 09 May 2024 |
1y target est | 29.26 |
Competition is heating up in the GLP-1 space as Amgen gets closer to the finish line with its candidate.
Insight into the Fund's Latest Investment Decisions and Stock Adjustments
Eli Lilly (LLY), Novo Nordisk (NVO), Pfizer (PFE) and AbbVie (ABBV) announce their first-quarter results.